Cargando…

Case Report: A Case Report and Literature Review on Severe Bullous Skin Reaction Induced by anti-PD-1 Immunotherapy in a Cervical Cancer Patient

Background: Anti-programmed cell death protein 1 (PD-1) has been successfully used in carcinomas treatment. However, it causes significant adverse effects (AEs), including cutaneous reactions, particularly the life-threatening severe bullous skin reactions (SBSR) and toxic epidermal necrolysis (TEN)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiang, Qu, Li-Xin, Ren, Yu-Mei, Hu, Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423354/ https://www.ncbi.nlm.nih.gov/pubmed/34504425 http://dx.doi.org/10.3389/fphar.2021.707967

Ejemplares similares

Bullous Pemphigoid as an Adverse Reaction to Pembrolizumab: Two Case Reports
por: Thomsen, Kenneth, et al.
Publicado: (2018)

Bullous scabies: a case report and review of the literature
por: Arif Maan, Muhammad Arslan, et al.
Publicado: (2015)

Leukemoid reaction in cervical cancer: a case report and review of the literature
por: Qing, Li, et al.
Publicado: (2014)

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
por: Liu, Jinhua, et al.
Publicado: (2021)

Comprehensive Evaluation of Anti-PD-1, Anti-PD-L1, Anti-CTLA-4 and Their Combined Immunotherapy in Clinical Trials: A Systematic Review and Meta-analysis
por: Xiang, Ze, et al.
Publicado: (2022)

PD-1/PD-L1 Inhibitors in Cervical Cancer
por: Liu, Yuncong, et al.
Publicado: (2019)

Trends in the Research Into Immune Checkpoint Blockade by Anti-PD1/PDL1 Antibodies in Cancer Immunotherapy: A Bibliometric Study
por: Sun, Yiting, et al.
Publicado: (2021)

Ciprofloxacin induced bullous fixed drug reaction: three case reports
por: Nair, Pragya A.
Publicado: (2015)

Case Report: Successful Avatrombopag Treatment for Two Cases of Anti-PD-1 Antibody-Induced Acquired Amegakaryocytic Thrombocytopenia
por: Tu, Xiaofang, et al.
Publicado: (2022)

BULLOUS APLASIA CUTIS CONGENITA: CASE REPORT AND REVIEW OF THE LITERATURE
por: Garcia-Romero, Maria Teresa, et al.
Publicado: (2011)

Bullous scabies in an adult: A case report with review of literature
por: Gutte, Rameshwar M.
Publicado: (2013)

Annular bullous pemphigoid: A case report and review of literature
por: Arès, Steffie, et al.
Publicado: (2022)

Bullous pemphigoid and radiotherapy: Case report and literature review update
por: Piras, Antonio, et al.
Publicado: (2022)

Case Report: Nintedanib for immune-related pneumonitis triggered by anti-PD-1 treatment in a patient with SMARCA4-mutant NSCLC: a case report
por: Deng, Changwen, et al.
Publicado: (2023)

Case Report: PTEN Mutation Induced by anti-PD-1 Therapy in Stage IV Lung Adenocarcinoma
por: Teng, Junjie, et al.
Publicado: (2022)

Case Report: Severe thrombocytopenia induced by adalimumab in rheumatoid arthritis: A case report and literature review
por: Liao, Tiantian, et al.
Publicado: (2022)

Localized bullous pemphigoid: a case report
por: Wang, Yiman, et al.
Publicado: (2020)

Bullous Pemphigoid with Atypical Skin Lesions and Acute Interstitial Nephritis: A Case Report and Focused Literature Review
por: Ganapathineedi, Bindu, et al.
Publicado: (2019)

Autoimmune Bullous Skin Disease Managed with Ayurvedic Treatment: A Case Report
por: Shingadiya, Rahul K, et al.
Publicado: (2017)

Erratum: Case report: PTEN mutation induced by anti-PD-1 therapy in stage IV lung adenocarcinoma
Publicado: (2022)

Baricitinib treatment for refractory skin changes in POEMS syndrome: a case report
por: Xie, Jingjing, et al.
Publicado: (2023)

Hemorrhagic Bullous Henoch-Schönlein Purpura: Case Report and Review of the Literature
por: Nothhaft, Matthias, et al.
Publicado: (2019)

Bullous Lichen Planus of the Nails: A Case Report and Review of the Literature
por: Hwang, Jonathan K., et al.
Publicado: (2023)

A case of drug-induced bullous pemphigoid secondary to immunotherapy treated with upadacitinib: A case report
por: Gresham, Louise M, et al.
Publicado: (2023)

Tozinameran: Bullous pemphigoid: case report
Publicado: (2022)

Tozinameran: Bullous pemphigoid: case report
Publicado: (2022)

Tozinameran: Bullous pemphigoid: case report
Publicado: (2022)

Tozinameran: Bullous pemphigoid: case report
Publicado: (2022)

Tozinameran: Bullous pemphigoid: case report
Publicado: (2022)

Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations
por: Souza, José Diogo S., et al.
Publicado: (2022)

A FAK Inhibitor Boosts Anti-PD1 Immunotherapy in a Hepatocellular Carcinoma Mouse Model
por: Wei, Yuhua, et al.
Publicado: (2022)

β-Glucan Combined With PD-1/PD-L1 Checkpoint Blockade for Immunotherapy in Patients With Advanced Cancer
por: Wang, Mengjie, et al.
Publicado: (2022)

Editorial: Natural products modulate the sensitivity of cancer to anti-PD-1 based immunotherapy
por: Chamcheu, Jean Christopher, et al.
Publicado: (2023)

Response to anti-PD1 immunotherapy in patients with metastatic cutaneous sarcoma: case reports and literature review
por: Vieira, Aline Cristini, et al.
Publicado: (2020)

Bullous vesicant-type reaction to docetaxel along the venous tract: A case report
por: Su, Jane, et al.
Publicado: (2020)

Mesenchymal stem cells elicits Anti-PD1 immunotherapy by targeted delivery of CX3CL1
por: Liu, Jize, et al.
Publicado: (2023)

Intravitreous injection of conbercept for bullous retinal detachment: A case report
por: Xiang, Xiao-Li, et al.
Publicado: (2022)

Comparisons of Underlying Mechanisms, Clinical Efficacy and Safety Between Anti-PD-1 and Anti-PD-L1 Immunotherapy: The State-of-the-Art Review and Future Perspectives
por: Zhao, Yating, et al.
Publicado: (2021)

Bullous Pemphigoid with Lymphocytic Colitis: A Case Report and Short Literature Review
por: Sperl, Alexandra, et al.
Publicado: (2016)

May Bacterial Infections Trigger Bullous Pemphigoid? Case Report and Review of Literature
por: Biondo, Michela Ileen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ug27u440bqnmk5kuees5s8pdmi